These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29871738)

  • 21. Severe psoriasis entering remission after treatment for latent tuberculosis with isoniazid: Report of two cases.
    Partarrieu-Mejías F; Hernández-Bel P; Giácaman-von der Weth M; Pérez-Ferriols A
    J Dermatol; 2019 Sep; 46(9):798-801. PubMed ID: 31325342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
    Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
    Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review.
    Lee EB; Amin M; Man J; Egeberg A; Wu JJ
    J Dermatolog Treat; 2018 Nov; 29(7):671-675. PubMed ID: 29455561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
    Tomono K; Hashimoto S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidenced-based guidelines for tuberculosis screening before biologic treatment initiation.
    Shah P; Rebick G; Bajaj S; Desvignes L; Lo Sicco K
    J Am Acad Dermatol; 2020 Jul; 83(1):e25-e26. PubMed ID: 32222451
    [No Abstract]   [Full Text] [Related]  

  • 27. Spontaneous Resolution of Enterocutaneous Fistula After Disseminated Tuberculosis Treatment in a Patient With Crohn's Disease: Challenges in Biologic Therapy.
    Silva JC; Rodrigues A; Carvalho J
    Inflamm Bowel Dis; 2020 Jan; 26(1):e1-e2. PubMed ID: 31750911
    [No Abstract]   [Full Text] [Related]  

  • 28. Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab.
    Nuño-González A; Dehesa L; Ricotti C; Kerdel F
    Actas Dermosifiliogr; 2012 Dec; 103(10):936-7. PubMed ID: 23149048
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to: "Evidence-based guidelines for tuberculosis screening before biologic treatment initiation".
    Fernandez AP; Ellis A; Khanna U; Galadari A
    J Am Acad Dermatol; 2020 Jul; 83(1):e27-e28. PubMed ID: 32222450
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clarifications to the consensus document on the diagnosis, treatment and prevention of tuberculosis].
    Peña JM
    Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):162-3; author reply 163-4. PubMed ID: 20888083
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon γ assays in the diagnosis of tuberculosis infection in psoriasis patients who are candidates for biologic therapies.
    Domínguez J; Vilavella M; Latorre I
    Actas Dermosifiliogr; 2012 Dec; 103(10):880-6. PubMed ID: 23157912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.
    Abreu C; Magro F; Santos-Antunes J; Pilão A; Rodrigues-Pinto E; Bernardes J; Bernardo A; Magina S; Vilas-Boas F; Lopes S; Macedo G; Sarmento A
    J Crohns Colitis; 2013 Nov; 7(10):e486-92. PubMed ID: 23583099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommendations for the prevention and management of tuberculosis in patients treated with tumor necrosis factor alpha inhibitors: a consensus of lithuanian pulmonologists and rheumatologists].
    Malakauskas K; Zablockis R; Venalis A; Butrimienė I; Baranauskaitė A; Nargėla RV; Sakalauskas R
    Medicina (Kaunas); 2011; 47(3):187-91. PubMed ID: 21822042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts.
    Sánchez-Moya AI; Daudén E
    Br J Dermatol; 2011 Jan; 164(1):208-9. PubMed ID: 21054332
    [No Abstract]   [Full Text] [Related]  

  • 36. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease.
    Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E
    Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.
    Hsia EC; Cush JJ; Matteson EL; Beutler A; Doyle MK; Hsu B; Xu S; Rahman MU
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):309-13. PubMed ID: 22782640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy.
    Mastorino L; Dapavo P; Trunfio M; Avallone G; Rubatto M; Calcagno A; Ribero S; Quaglino P
    Acta Derm Venereol; 2022 Nov; 102():adv00821. PubMed ID: 36065745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for tuberculosis infection prior to medical therapy].
    Ravn P
    Ugeskr Laeger; 2011 Mar; 173(12):893-6. PubMed ID: 21419060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hidradenitis suppurativa. Response to treatment with infliximab].
    Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
    Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.